Maruxa Diaz Fidalgo

Maruxa Diaz Fidalgo has a diverse work experience in the healthcare and pharmaceutical industry. Maruxa is currently working as the Global Patient Access Associate Director at Sobi - Swedish Orphan Biovitrum AB (publ), where they have been since 2018. Maruxa is also the Global Business Development Manager at the same company.

Prior to their current role, Maruxa worked at Novartis Oncology from 2014 to 2018. During their time there, they held various positions including HEOR Manager and Value Access Manager in the Market Access Department. Maruxa was responsible for developing product value stories, economic tools for price and reimbursement negotiation, and implementing value-added proposals for the Oncology, Hematology, and Rare Disease portfolio. Maruxa also worked on loss of exclusivity strategy and management and was involved in innovation projects for the Rare Diseases Franchise.

Before joining Novartis, Maruxa worked at PwC as a Healthcare & Pharma Senior Consultant from 2011 to 2014. Their role involved redesigning organization structures in pharmaceutical companies and implementing access strategies in the oncology market.

Maruxa started their career at Mensor Consulting and Strategy as a Healthcare & Pharma Consultant from 2007 to 2011. Maruxa worked on research projects in biomedicine, including the Oncosur Strategy Plan, and innovation projects for the biotechnology sector in Cantabria.

Maruxa also has experience working at Hôpital Européen George Pompidou - Paris in the Pharmacy Service from 2005 to 2006.

Overall, Maruxa Diaz Fidalgo has held various roles in the healthcare and pharmaceutical industry, focusing on market access, value proposition, and innovation in rare diseases and oncology.

Maruxa Diaz Fidalgo's education history includes a Master en Market Access en el Sector Salud from MPG - European Health School in 2016, an Advanced HTA Course and a Health Technology Assessment Course from the School of Health and Related Research at the University of Sheffield in 2015, a Master in Health Economics and Pharmaeconomics from Universitat Pompeu Fabra from 2015 to 2017, a Master in Business Administration - MBA from IE Business School in 2006-2007, and a Degree in Pharmacy from Universidad Complutense de Madrid with an excellent academic record award from the "Fundación Rafael Folch" in 2000-2005.